Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
ROCKVILLE, Md. (AP) _ MacroGenics Inc. (MGNX) on Thursday reported a loss of $46.9 million in its second quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of 94 cents.
The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 88 cents per share.
The biopharmaceutical company posted revenue of $20.3 million in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $14.2 million.
Insight by Carahsoft: Explore use cases for edge computing and approaches for taking advantage of it by downloading this exclusive e-book.
MacroGenics shares have more than doubled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $26.75, an increase of 82% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGNX at https://www.zacks.com/ap/MGNX
Copyright © 2021 . All rights reserved. This website is not intended for users located within the European Economic Area.